MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.47 -0.23 (-1.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Depreciation & Amortization (CF) (2021 - 2026)

Updated

MoonLake Immunotherapeutics (MLTX) posted Depreciation & Amortization (CF) of $896,000 for Q2 2026, up 24.4% from $720,000 a year earlier and up 6.0% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at MoonLake Immunotherapeutics was $3.24 million, up 77.9% year-over-year; for FY2025, it was $2.62 million, up 86.9% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for three consecutive years, with a four-year compound annual growth rate of 379.0% (FY2021 to FY2025).
  • In prior years, MoonLake Immunotherapeutics' Depreciation & Amortization (CF) was $1.4 million in FY2024 (+250.0%), $400,000 in FY2023 (+100.0%), $200,000 in FY2022 and $4,971 in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2021.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last six quarters, with growth averaging 80.5% over the last six quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2025, with growth of 143.0%; the weakest was Q3 2023, with a decline of 0.1%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $845,000 (Q1 2026), $716,000 (Q4 2025) and $780,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 MoonLake Immunotherapeutics 995.75 Mn -673.65 Mn - 896,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 896,000.00
Mar 31, 2026 845,000.00
Dec 31, 2025 716,000.00
Sep 30, 2025 780,000.00
Jun 30, 2025 720,000.00
Mar 31, 2025 400,000.00
Dec 31, 2024 379,000.00
Sep 30, 2024 321,000.00
Jun 30, 2024 372,000.00
Mar 31, 2024 328,000.00
Dec 31, 2023 3,289.00
Sep 30, 2023 3,290.00
Jun 30, 2023 3,289.00
Mar 31, 2023 3,290.00
Dec 31, 2022 3,289.00
Sep 30, 2022 3,293.00
Jun 30, 2022 3,288.00
Mar 31, 2022 2,488.00
Dec 31, 2021 2,487.00
Sep 30, 2021 2,271.00
API Access

MoonLake Immunotherapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MLTX&period=max&api_key=YOUR_API_KEY